Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorCombined Modality TherapyLeukapheresisHematologic NeoplasmsAntigens, CD34Antineoplastic Combined Chemotherapy ProtocolsBlood Component RemovalCyclophosphamideStem Cell TransplantationMultiple MyelomaMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalEtoposideHematopoietic Stem CellsThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCarmustineCytophagocytosisIfosfamideSalvage TherapyVincristineAmyloidosisCytarabineDisease-Free SurvivalHodgkin DiseaseStem CellsHematopoiesisCord Blood Stem Cell TransplantationNeoplasmsTransplantation ChimeraSurvival RateRetrospective StudiesTissue DonorsDoxorubicinSurvival AnalysisWhole-Body IrradiationTime FactorsInfectionLymphoma, T-CellCarboplatinPOEMS SyndromeHistocompatibilityPlatelet CountAntineoplastic AgentsHistocompatibility TestingPrednisoneLeukemia, Myeloid, AcuteImmunosuppressive AgentsDexamethasoneFollow-Up StudiesTransplantation, IsogeneicVidarabineBlood Cell CountRecombinant ProteinsLeukemiaBone Marrow PurgingProspective StudiesLymphomaBlood CellsFatal OutcomeCytomegalovirus InfectionsFeasibility StudiesGraft vs Leukemia EffectMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticPrognosisBreast NeoplasmsBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationLymphocyte DepletionHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukocytes, MononuclearT-LymphocytesBone MarrowHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsLivedo ReticularisHLA AntigensCyclosporineBlood DonorsImmunosuppressionCell SeparationPilot Projects